(Q37981135)

26 August 2017

title

The antioxidant enzyme peroxiredoxin and its protective role in neurological disorders (English)

1 reference

26 August 2017

Hong Zhu

1

1 reference

26 August 2017

Arben Santo

series ordinal

2

1 reference

26 August 2017

Yunbo Li

series ordinal

3

1 reference

26 August 2017

publication date

2 February 2012

1 reference

Experimental Biology and Medicine

26 August 2017

published in

1 reference

26 August 2017

volume

237

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

143-149

1 reference

Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Structure, mechanism and regulation of peroxiredoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A₂ activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Investigating transcriptional regulation of Prdx6 in mouse liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Human prx1 gene is a target of Nrf2 and is up-regulated by hypoxia/reoxygenation: implication to tumor biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Oxidant stress stimulates expression of the human peroxiredoxin 6 gene by a transcriptional mechanism involving an antioxidant response element

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Mitochondrial targeting of human peroxiredoxin V protein and regulation of PRDX5 gene expression by nuclear transcription factors controlling biogenesis of mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

FOXO3A regulates peroxiredoxin III expression in human cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Typical 2-Cys peroxiredoxins--modulation by covalent transformations and noncovalent interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Peroxiredoxin distribution in the mouse brain with emphasis on neuronal populations affected in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Peroxiredoxin 6 in human brain: molecular forms, cellular distribution and association with Alzheimer's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

The science of stroke: mechanisms in search of treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Changes in the expression of mitochondrial peroxiredoxin and thioredoxin in neurons and glia and their protective effects in experimental cerebral ischemic damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Microglia in ischemic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Targeting astrocytes for stroke therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Murine thioredoxin peroxidase delays neuronal apoptosis and is expressed in areas of the brain most susceptible to hypoxic and ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Peroxiredoxin 2 overexpression protects cortical neuronal cultures from ischemic and oxidative injury but not glutamate excitotoxicity, whereas Cu/Zn superoxide dismutase 1 overexpression protects only against oxidative injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Silencing of peroxiredoxin 3 and peroxiredoxin 5 reveals the role of mitochondrial peroxiredoxins in the protection of human neuroblastoma SH-SY5Y cells toward MPP+

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Interaction of amyloid binding alcohol dehydrogenase/Abeta mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Saitohin, which is nested in the tau locus and confers allele-specific susceptibility to several neurodegenerative diseases, interacts with peroxiredoxin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Peroxiredoxin II preserves cognitive function against age-linked hippocampal oxidative damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Reactive oxygen species are NOXious for neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

S-nitrosylation/activation of COX-2 mediates NMDA neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Mitochondrial peroxiredoxin-3 protects hippocampal neurons from excitotoxic injury in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Recombinant peroxiredoxin 5 protects against excitotoxic brain lesions in newborn mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Expression and changes of hyperoxidized peroxiredoxins in non-pyramidal and polymorphic cells in the gerbil hippocampus during normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

JNK/FOXO-mediated neuronal expression of fly homologue of peroxiredoxin II reduces oxidative stress and extends life span

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Biomarker discovery: a proteomic approach for brain cancer profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Specific expression profile and prognostic significance of peroxiredoxins in grade II-IV astrocytic brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Obovatol attenuates microglia-mediated neuroinflammation by modulating redox regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Polyphenolic phytochemicals--just antioxidants or much more?

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Polymeric black tea polyphenols induce phase II enzymes via Nrf2 in mouse liver and lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Tea, flavonoids and stroke in man and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Ferulic acid inhibits oxidative stress and cell death induced by Ab oligomers: improved delivery by solid lipid nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Icariin inhibits hydrogen peroxide-mediated cytotoxicity by up-regulating sirtuin type 1-dependent catalase and peroxiredoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Sirtuins: common targets in aging and in neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Quercetin induces the expression of peroxiredoxins 3 and 5 via the Nrf2/NRF1 transcription pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Hydroxytyrosol protects against oxidative damage by simultaneous activation of mitochondrial biogenesis and phase II detoxifying enzyme systems in retinal pigment epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Induction of sulfiredoxin expression and reduction of peroxiredoxin hyperoxidation by the neuroprotective Nrf2 activator 3H-1,2-dithiole-3-thione.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Identification of proteins differentially expressed by melatonin treatment in cerebral ischemic injury--a proteomics approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Potent induction of total cellular GSH and NQO1 as well as mitochondrial GSH by 3H-1,2-dithiole-3-thione in SH-SY5Y neuroblastoma cells and primary human neurons: protection against neurocytotoxicity elicited by dopamine, 6-hydroxydopamine, 4-hydrox

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Upregulation of cellular glutathione by 3H-1,2-dithiole-3-thione as a possible treatment strategy for protecting against acrolein-induced neurocytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

Cruciferous nutraceutical 3H-1,2-dithiole-3-thione protects human primary astrocytes against neurocytotoxicity elicited by MPTP, MPP(+), 6-OHDA, HNE and acrolein

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FEBM.2011.011152

21 January 2018

Identifiers

DOI

10.1258/EBM.2011.011152

1 reference

26 August 2017

1 reference